Pharmacological tools for manipulating the epigenome (March 21, 2025)

"Pharmacological tools for manipulating the epigenome" Cheryl H. Arrowsmith, Ph.D., FRSC, Professor, Department of Medical Biophysics, University of Toronto, Senior Scientist, Princess Margaret Cancer Centre, Chief Scientist - Structural Genomics Consortium, University of Toronto "Investigation into the role of NSD2 for small cell lung cancer progressiont" Riley Horvath, Postdoctoral Researcher, University of Toronto